Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,772 across all filing types
Latest filing 2026-01-12 Major Shareholding Noti…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of major holdings (voting rights) under the German Securities Trading Act (WpHG). It details the acquisition of shares by Triton GP HoldCo SARL in Evotec SE, crossing a specific threshold. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2026-01-12 English
Just Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Regulatory Filings Classification · 1% confidence The document is a corporate news announcement regarding a grant received by Evotec SE's subsidiary, Just – Evotec Biologics. It details the nature of the grant, the technology involved, and the strategic implications for the company. It does not fit into specific categories like financial reports, proxy statements, or director dealings. As it is a general corporate news release disseminated via a regulatory news service (EQS), it falls under the 'Regulatory Filings' category as the appropriate fallback for miscellaneous corporate announcements.
2026-01-08 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of major holdings (voting rights) filed by JPMorgan Chase & Co. regarding their interest in Evotec SE. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act), which is the standard regulatory framework for major shareholding notifications in Germany. The content details the percentage of voting rights and financial instruments held, fitting the definition of a Major Shareholding Notification.
2026-01-06 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of major holdings (voting rights) filed by JPMorgan Chase & Co. regarding their interest in Evotec SE. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act) and provides detailed tables regarding voting rights, instruments, and controlled undertakings. This aligns perfectly with the definition of a Major Shareholding Notification.
2026-01-02 English
Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Board/Management Information Classification · 1% confidence The document is a corporate news announcement regarding the appointment of a new Executive Vice President, Head of Global Communications and Investor Relations at Evotec SE. This falls under the category of management changes, which is specifically defined as 'Board/Management Information' (MANG).
2026-01-01 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of major holdings (voting rights) filed by JPMorgan Chase & Co. regarding their interest in Evotec SE. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act) and provides detailed tables on voting rights, instruments, and controlled undertakings. This aligns perfectly with the definition of a Major Shareholding Notification.
2025-12-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.